6 completed, 2 recruiting, 1 active not recruiting, 1 not yet recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Immunocompromised Host: new trials by email Literature Review of Immunocompromised Host trials Research Report on Immunocompromised Host
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aztreonam-Avibactam in Immunocompromised Hosts Aztreonam-Avibactam, Ceftazidime-Avibactam Plus Aztreonam - Enterobacteriaceae Infections, Carbapenem-Resistant Enterobacteriaceae Infection | Recruiting | Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno | 814 | 2026-10-14 | 2026-10-27 | |
| Metagenomic Sequencing Across the Infectious Disease Risk and Care Continuum Infectious Diseases, Immunocompromised Host | Not yet recruiting | Karius, Inc. | 10000 | 2026-10-01 | 2026-09-17 | |
| COVID-19 Booster and IIV Schedule in Immunocompromised Hosts Inactivated influenza vaccine (IIV) at baseline, COVID-19 Vaccines at a 3-month interval, Inactivated influenza vaccine at Month 1 - COVID 19, Influenza | Phase 2 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 660 | 2024-11-20 | 2026-10-26 |
| Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort. COVID-19, Immunocompromised Host | Completed | ANRS, Emerging Infectious Diseases | 149 | 2022-01-26 | 2025-01-29 | |
| ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients Immunocompromised Host, Critical Care | Completed | University Hospital, Lille | 759 | 2019-11-07 | 2022-10-05 | |
| Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens Karius Test - Pneumonia, Bacterial, Pneumonia, Viral | Completed | Karius, Inc. | 257 | 2019-11-05 | 2023-02-09 | |
| Oxygen Therapy During Acute Respiratory Failure in Immuno-compromised Patients High Flow Nasal Canula (HFNC), Venturi mask, Oxygen - Acute Respiratory Failure, Immunocompromised Host | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 100 | 2012-11-01 | 2016-04-18 |
| RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults Respiratory Syncytial Virus Infections, Immunocompromised Host | Active not recruiting | Hospital Italiano de Buenos Aires | 350 | 2011-11-01 | 2026-09-11 | |
| Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis Immunocompromised Host, Invasive Pulmonary Fungal Infection | Completed | National Cancer Institute (NCI) | 2009-03-30 | 2017-07-02 | ||
| Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease Immunocompromised Host, Organ Transplantation | Completed | National Cancer Institute (NCI) | 19929901 | 2006-07-01 | 2020-04-28 |
COVID-19 (3) · Influenza, Human (2) · Pneumonia, Viral (2) · Arthritis, Rheumatoid (1) · Communicable Diseases (1) · Enterobacteriaceae Infections (1) · Hematologic Neoplasms (1) · Inflammatory Bowel Diseases (1) · Invasive Pulmonary Aspergillosis (1) · Kidney Failure, Chronic (1) · Lymphopenia (1) · Mycoses (1) · Neoplasms (1) · Neutropenia (1) · Opportunistic Infections (1)
Infections (7) · Lung Diseases (5) · Respiratory Tract Diseases (5) · Respiratory Tract Infections (4) · Virus Diseases (4) · Bacterial Infections and Mycoses (3) · Coronaviridae Infections (3) · Coronavirus Infections (3) · Nidovirales Infections (3) · Pneumonia (3) · RNA Virus Infections (3) · Bacterial Infections (2) · Disease Attributes (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2)
Aztreonam (1) · Oxygen (1) · avibactam, ceftazidime drug combination (1)
Karius, Inc. (2) · National Cancer Institute (NCI) (2) · ANRS, Emerging Infectious Diseases (1) · Assistance Publique - Hôpitaux de Paris (1) · Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno (1) · Hospital Italiano de Buenos Aires (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · University Hospital, Lille (1)
United States (3) · France (2) · Argentina (1) · Canada (1)
Diego Torres, MD (1) · Eric A Engels, M.D. (1) · Kat Kwiatkowski, PhD (1) · Maximiliano Gabriel Castro, MD (1) · Stephen Bergin, MD (1)
PMID 26521922, PMID 36216187, PMID 37815489
2025 (1)